Viruses 2009, 1(3), 594-629; doi:10.3390/v1030594
Review

Herpes Virus Amplicon Vectors

1,2,3email and 2,3,4,5,* email
Received: 30 September 2009; in revised form: 26 October 2009 / Accepted: 29 October 2009 / Published: 29 October 2009
(This article belongs to the Special Issue Novel Viral Vector Systems for Gene Therapy)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Since its emergence onto the gene therapy scene nearly 25 years ago, the replication-defective Herpes Simplex Virus Type-1 (HSV-1) amplicon has gained significance as a versatile gene transfer platform due to its extensive transgene capacity, widespread cellular tropism, minimal immunogenicity, and its amenability to genetic manipulation. Herein, we detail the recent advances made with respect to the design of the HSV amplicon, its numerous in vitro and in vivo applications, and the current impediments this virus-based gene transfer platform faces as it navigates a challenging path towards future clinical testing.
Keywords: herpes simplex virus; HSV amplicon; gene transfer; immunotherapy; integration
PDF Full-text Download PDF Full-Text [369 KB, uploaded 29 October 2009 17:01 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

De Silva, S.; Bowers, W.J. Herpes Virus Amplicon Vectors. Viruses 2009, 1, 594-629.

AMA Style

De Silva S, Bowers WJ. Herpes Virus Amplicon Vectors. Viruses. 2009; 1(3):594-629.

Chicago/Turabian Style

De Silva, Suresh; Bowers, William J. 2009. "Herpes Virus Amplicon Vectors." Viruses 1, no. 3: 594-629.


Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert